{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:37:04Z","timestamp":1778071024864,"version":"3.51.4"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0093637","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T22:56:37Z","timestamp":1396479397000},"page":"e93637","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cerebrospinal Fluid Biomarker Candidates Associated with Human WNV Neuroinvasive Disease"],"prefix":"10.1371","volume":"9","author":[{"given":"Christophe","family":"Fraisier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Papa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Granjeaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogier","family":"Hintzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron","family":"Martina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Camoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Almeras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vetmic.2009.08.025","article-title":"Zoonotic mosquito-borne flaviviruses: worldwide presence of agents with proven pathogenicity and potential candidates of future emerging diseases","volume":"140","author":"H Weissenbock","year":"2010","journal-title":"Vet Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00705-012-1516-3","article-title":"West Nile virus associations in wild mammals: a synthesis","volume":"158","author":"J Jeffrey Root","year":"2013","journal-title":"Arch Virol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cll.2009.10.006","article-title":"West Nile virus","volume":"30","author":"SL Rossi","year":"2010","journal-title":"Clin Lab Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1750-3639.2003.tb00477.x","article-title":"Fatal fulminant pan-meningo-polioencephalitis due to West Nile virus","volume":"13","author":"BI Omalu","year":"2003","journal-title":"Brain Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1297-9716-43-16","article-title":"Recent progress in West Nile virus diagnosis and vaccination","volume":"43","author":"M De Filette","year":"2012","journal-title":"Vet Res"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Sambri V, Capobianchi M, Charrel R, Fyodorova M, Gaibani P, <etal>et al<\/etal>.. (2013) West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. Clin Microbiol Infect.","DOI":"10.1111\/1469-0691.12211"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Papa A, Danis K, Baka A, Bakas A, Dougas G, <etal>et al<\/etal>.. (2010) Ongoing outbreak of West Nile virus infections in humans in Greece, July-August 2010. Euro Surveill 15.","DOI":"10.2807\/ese.15.34.19644-en"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3201\/eid1710.110525","article-title":"Outbreak of West Nile virus infection in Greece, 2010","volume":"17","author":"K Danis","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Rizzo C, Salcuni P, Nicoletti L, Ciufolini MG, Russo F, <etal>et al<\/etal>.. (2012) Epidemiological surveillance of West Nile neuroinvasive diseases in Italy, 2008 to 2011. Euro Surveill 17.","DOI":"10.2807\/ese.17.20.20172-en"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1586\/eri.12.59","article-title":"West Nile virus infections in Greece: an update","volume":"10","author":"A Papa","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1089\/vbz.2010.0206","article-title":"Reemergence of human infections with West Nile virus in Romania, 2010: an epidemiological study and brief review of the past situation","volume":"11","author":"AM Neghina","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3390\/ijerph10083543","article-title":"Environmental drivers of west nile Fever epidemiology in europe and Western Asia-a review","volume":"10","author":"S Paz","year":"2013","journal-title":"Int J Environ Res Public Health"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Beasley DW, Barrett AD, Tesh RB (2013) Resurgence of West Nile neurologic disease in the United States in 2012: What happened? What needs to be done? Antiviral Res.","DOI":"10.1016\/j.antiviral.2013.04.015"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1399-3062.2002.01014.x","article-title":"Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis","volume":"4","author":"A Hamdan","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3201\/eid0704.017432","article-title":"Treatment of West Nile virus encephalitis with intravenous immunoglobulin","volume":"7","author":"Z Shimoni","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"ref16","first-page":"17","article-title":"[Ribavirin prophylaxis and therapy of experimental West Nile fever]","volume":"54","author":"S Loginova","year":"2009","journal-title":"Antibiot Khimioter"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1086\/315847","article-title":"Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells","volume":"182","author":"I Jordan","year":"2000","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/427945","article-title":"Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases","volume":"40","author":"AC Kalil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1017\/S031716710005383X","article-title":"Calgary experience with West Nile virus neurological syndrome during the late summer of 2003","volume":"31","author":"AL Sayao","year":"2004","journal-title":"Can J Neurol Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1016\/j.vaccine.2006.12.005","article-title":"West Nile virus: recent trends in diagnosis and vaccine development","volume":"25","author":"G Dauphin","year":"2007","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/v3060811","article-title":"West Nile virus: immunity and pathogenesis","volume":"3","author":"SM Lim","year":"2011","journal-title":"Viruses"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/viru.19697","article-title":"Blood-brain barrier and retroviral infections","volume":"3","author":"F Miller","year":"2012","journal-title":"Virulence"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpn.2012.09.005","article-title":"Cerebrospinal fluid biomarkers in neurological diseases in children","volume":"17","author":"P Shahim","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CMR.00045-12","article-title":"West Nile Virus: biology, transmission, and human infection","volume":"25","author":"TM Colpitts","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcv.2004.05.017","article-title":"Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease","volume":"31","author":"H Kapoor","year":"2004","journal-title":"J Clin Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1086\/375692","article-title":"Plasma cell pleocytosis in cerebrospinal fluid in patients with West Nile virus encephalitis","volume":"37","author":"PJ Carson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1212\/01.wnl.0000195890.70898.1f","article-title":"CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis","volume":"66","author":"KL Tyler","year":"2006","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3122\/jabfm.17.6.470","article-title":"Cerebrospinal fluid neutrophilic pleocytosis in hospitalized West Nile virus patients","volume":"17","author":"R Crichlow","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"697418","DOI":"10.1155\/2012\/697418","article-title":"Plasma cell cerebrospinal fluid pleocytosis does not predict West Nile virus infection","volume":"2012","author":"M Jordan","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.21448","article-title":"Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection","volume":"41","author":"A Petzold","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/mus.23241","article-title":"Glial S100B is elevated in serum across the spectrum of West Nile virus infection","volume":"45","author":"AA Leis","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2006-9309","article-title":"Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders","volume":"9","author":"F Abdi","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e17287","DOI":"10.1371\/journal.pone.0017287","article-title":"Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome","volume":"6","author":"SE Schutzer","year":"2011","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jprot.2008.11.014","article-title":"Identification of novel candidate protein biomarkers for the post-polio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation","volume":"71","author":"H Gonzalez","year":"2009","journal-title":"J Proteomics"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2007.08.004","article-title":"CSF proteomic fingerprints for HIV-associated cognitive impairment","volume":"192","author":"JP Laspiur","year":"2007","journal-title":"J Neuroimmunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/nprot.2010.123","article-title":"Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS\/MS","volume":"5","author":"RD Unwin","year":"2010","journal-title":"Nat Protoc"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1475-2875-9-141","article-title":"Plasmodium falciparum proteome changes in response to doxycycline treatment","volume":"9","author":"S Briolant","year":"2010","journal-title":"Malar J"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Fraisier C, Rodrigues R, Hai VV, Belghazi M, Bourdon S, <etal>et al<\/etal>.. (2013) Hepatocyte pathway alterations in response to in vitro Crimean Congo hemorrhagic fever virus infection. Virus Res (in press).","DOI":"10.1016\/j.virusres.2013.10.013"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e68318","DOI":"10.1371\/journal.pone.0068318","article-title":"Altered protein networks and cellular pathways in severe west nile disease in mice","volume":"8","author":"C Fraisier","year":"2013","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"MS Diamond","year":"2003","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/CDLI.12.1.231-233.2005","article-title":"Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay","volume":"12","author":"HE Prince","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcv.2006.07.005","article-title":"West Nile virus immunoglobulin A (WNV IgA) detection in cerebrospinal fluid in relation to WNV IgG and IgM reactivity","volume":"37","author":"ML Nixon","year":"2006","journal-title":"J Clin Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/591467","article-title":"Virus and antibody dynamics in acute west nile virus infection","volume":"198","author":"MP Busch","year":"2008","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1021\/pr070293w","article-title":"Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis","volume":"6","author":"KS Shores","year":"2007","journal-title":"J Proteome Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1182\/blood.V96.9.3086","article-title":"The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations","volume":"96","author":"B Agerberth","year":"2000","journal-title":"Blood"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0952-7915(94)90145-7","article-title":"Defensins","volume":"6","author":"T Ganz","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1615\/CritRevImmunol.v26.i6.60","article-title":"Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties","volume":"26","author":"F Niyonsaba","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.humimm.2013.05.008","article-title":"Defensins: Natural component of human innate immunity","volume":"74","author":"J Jarczak","year":"2013","journal-title":"Hum Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/JVI.60.3.1068-1074.1986","article-title":"Direct inactivation of viruses by human granulocyte defensins","volume":"60","author":"KA Daher","year":"1986","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/521027","article-title":"alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s)","volume":"196","author":"M Salvatore","year":"2007","journal-title":"J Infect Dis"},{"key":"ref51","first-page":"839458","article-title":"Two case reports of neuroinvasive west nile virus infection in the critical care unit","volume":"2012","author":"EM Flores Anticona","year":"2012","journal-title":"Case Rep Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"43855","DOI":"10.1074\/jbc.M111.299248","article-title":"Lipocalin-2 Is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration","volume":"286","author":"S Lee","year":"2011","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1073\/pnas.1218497110","article-title":"Reactive astrocytes secrete lcn2 to promote neuron death","volume":"110","author":"F Bi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/glia.22342","article-title":"Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis","volume":"60","author":"JL Berard","year":"2012","journal-title":"Glia"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fncel.2012.00033","article-title":"Lipocalin 2 is present in the EAE brain and is modulated by natalizumab","volume":"6","author":"F Marques","year":"2012","journal-title":"Front Cell Neurosci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.jcbfm.9600557","article-title":"Lipocalin 2 is a choroid plexus acute-phase protein","volume":"28","author":"F Marques","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref57","first-page":"129","article-title":"The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer","volume":"1826","author":"S Chakraborty","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2741\/1883","article-title":"Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain","volume":"11","author":"Y Gasche","year":"2006","journal-title":"Front Biosci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"e50430","DOI":"10.1371\/journal.pone.0050430","article-title":"Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction","volume":"7","author":"KA Thibert","year":"2012","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/tp.2012.64","article-title":"A molecular characterization of the choroid plexus and stress-induced gene regulation","volume":"2","author":"M Sathyanesan","year":"2012","journal-title":"Transl Psychiatry"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1743-422X-8-197","article-title":"Role of adhesion molecules and inflammation in Venezuelan equine encephalitis virus infected mouse brain","volume":"8","author":"A Sharma","year":"2011","journal-title":"Virol J"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000330095","article-title":"S100A8 and S100A9: new insights into their roles in malignancy","volume":"4","author":"G Srikrishna","year":"2012","journal-title":"J Innate Immun"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jemt.10299","article-title":"S100A9\/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity","volume":"60","author":"W Nacken","year":"2003","journal-title":"Microsc Res Tech"},{"key":"ref64","first-page":"100","article-title":"Review of S100A9 biology and its role in cancer","volume":"1835","author":"J Markowitz","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref65","unstructured":"Poynton RA, Hampton MB (2013) Peroxiredoxins as biomarkers of oxidative stress. Biochim Biophys Acta."},{"key":"ref66","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1096\/fj.13-227298","article-title":"Neutrophil-mediated oxidation of erythrocyte peroxiredoxin 2 as a potential marker of oxidative stress in inflammation","volume":"27","author":"SB Bayer","year":"2013","journal-title":"FASEB J"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12031-008-9075-5","article-title":"Peroxiredoxin 2 is involved in the neuroprotective effects of PACAP in cultured cerebellar granule neurons","volume":"36","author":"B Botia","year":"2008","journal-title":"J Mol Neurosci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0093637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:38:56Z","timestamp":1648748336000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0093637"}},"subtitle":[],"editor":[{"given":"Tian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,2]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0093637","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,2]]}}}